Recruiting NA Patient Satisfaction

New treatment option for Patient Satisfaction

Official title Predicting Ultrasound-Guided Thoracic PVB Success in Herpetic Neuralgia

ClinicalTrials.gov ID: NCT06761924

What this study is testing

What it's testing
This study aims to fill the knowledge gap by investigating the predictors of success for TPVB in patients with herpetic neuralgia. By identifying demographic, clinical, previous medications and procedural factors associated with positive outcomes, this research seeks to enhance the efficacy of TPVB and improve pain management strategies for patients suffering from herpetic neuralgia.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 70

You may be able to join if

  • Adults aged from18 to 70 years
  • Diagnosed with herpetic neuralgia.
  • Able and willing to provide informed consent.
  • ASA I - II
  • One dermatomal affection

You likely can't join if

  • Contraindications to TPVB as ( Infection at site of injection, empyema , coagulopathy and neoplastic lesion occupying the paravertebral space)
  • Known allergies to study medications (bupivacaine, Dexamethasone).
  • Severe comorbidities that could interfere with study participation.
See the full eligibility criteria
Who can join
  • Adults aged from18 to 70 years
  • Diagnosed with herpetic neuralgia.
  • Able and willing to provide informed consent.
  • ASA I - II
  • One dermatomal affection
  • Thoracic distribution
What rules you out
  • Contraindications to TPVB as ( Infection at site of injection, empyema , coagulopathy and neoplastic lesion occupying the paravertebral space)
  • Known allergies to study medications (bupivacaine, Dexamethasone).
  • Severe comorbidities that could interfere with study participation.

The study team makes the final eligibility decision.

Where it's taking place

  • Banī Suwayf, Beni Suweif Governorate, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Banī Suwayf, Beni Suweif Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.